Stockscreener 앱 받기
0.00
100.00%
-0.0111
시간 외 거래:
.01
0.01
+
Trevena Inc 주식(TRVN)의 최신 뉴스
Diabetic Peripheral Neuropathy Pipeline Accelerates as 15+ - openPR.com
Opioids Market Size, Share, Growth, Analysis, Report, 2034 - Straits Research
Trevena Inc stock (US89365K1007): low-priced biotech name draws speculative interest despite limited - AD HOC NEWS
Europe Stocks: Research Stocks from Europe Stock Market - GuruFocus
Number of shareholders of Trevena, Inc. – OTC:TRVN - TradingView
Trevena Inc stock (US89365K1007): biotech minnow fights for time after Nasdaq delisting and restruct - AD HOC NEWS
Number of shareholders of Trevena, Inc. – MUN:6T4 - TradingView
Trevena stock (US89365K1007): pipeline setbacks, Nasdaq pressure and what investors should know now - AD HOC NEWS
Trevena Inc stock (US89365K1007): Trading at $0.011 amid biopharma challenges - AD HOC NEWS
Catalent, Inc. Common Stock (NY: CTLT - FinancialContent
Trevena Inc (TRVN) Stock Price & 30 Year Financial Data - GuruFocus
Trevena Inc (TRVN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Trevena Inc (OTCM:TRVN) Stock Earnings Transcripts - GuruFocus
Trevena Inc (OTCM:TRVN) Dividend - GuruFocus
Trevena Inc (OTCM:TRVN) SEC filings - GuruFocus
Trevena Inc (OTCM:TRVN) Insider Trading Activity | Apple Insider Buys and Sells - GuruFocus
Trevena Inc stock (US89365K1007): Biopharma firm focuses on pain and CNS pipeline amid cash burn con - AD HOC NEWS
Health News Round upopioid pain drugs, Ebola vaccinations in Uganda and much mmore - Devdiscourse
Diabetic Neuropathy Pipeline Set for Significant - openPR.com
Diabetic Neuropathy Pipeline Set for Significant Breakthroughs by 2026 with 20+ Therapies and Robust Clinical Advancements | DelveInsight - Barchart.com
Polaris Venture Partners V L P Net WorthInsider Trades and Bio as of Apr 22, 2026 - Benzinga
Verastem, Inc. (VSTM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight - Barchart.com
TherapeuticsMD, Inc. (TXMD) stock price, news, quote and history - Yahoo Finance UK
Trevena (STU:6T4) PB Ratio : (As of Mar. 28, 2026) - gurufocus.com
Stock List: Research Stocks from Around the World - GuruFocus
SMX (Security Matters) Public Limited CompanyOrdinary Shares (NQ: SMX - The Chronicle-Journal
Wall Street closes lower, as war on Iran fuels inflation worries - marketscreener.com
S&P Closes Out Third Straight Week of Loses | Closing Bell - marketscreener.com
US Stocks Brief: S&P Futures Down 0.25% - marketscreener.com
Elon Musk's SpaceX weighs Nasdaq listing, sources say - marketscreener.com
Celebrity-studded Caliwater bets cactus is next big wave in hydration - Food Dive
Wall Street opens lower as investors weigh Middle East war risks - marketscreener.com
TRVN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Trump Says Stock Market Hit 53 New Highs on His Watch - marketscreener.com
US software stocks climb as Anthropic announcement sparks relief rally - marketscreener.com
VINC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
U.S. S&P 500 E-mini and Nasdaq 100 futures flat, Dow futures down 0.1% - marketscreener.com
Wall Street ends higher, lifted by Nvidia and other AI stocks - marketscreener.com
Tg-17 Inc changes corporate name to Our Bond, Inc. - marketscreener.com
Coinshares Updates on Fourth Quarter, Plans $0.33 Dividend Per Share - marketscreener.com
Investor Increases its Stake in Nasdaq - marketscreener.com
Why Arcadium Lithium Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket - Intellectia AI
Novakand Pharma applies for Nasdaq's approval of continued listing - marketscreener.com
S&P 500, Nasdaq turn negative; S&P down 0.4%, Nasdaq falls 0.9% - marketscreener.com
Braiin Shares to Begin Trading on Nasdaq - marketscreener.com
Columbus Circle Capital Corp II Prices $200 Million Initial Public Offering - marketscreener.com
Sanofi Concludes $2.2 Billion Takeover of Dynavax Technologies - marketscreener.com
Spring Valley Acquisition Corp. IV Prices $200 Million IPO - marketscreener.com
Caliwater hires first CEO - Food Business News
Unique Global Innovative Solutions Corp. (Ugiz) announces intent to pursue Nasdaq uplisting and capital raise - marketscreener.com
Generate Biomedicines Inc announces initial public offering - marketscreener.com
RCI Hospitality Receives Non-Compliance Letter from Nasdaq - marketscreener.com
Earnings Flash (NDAQ) Nasdaq Posts Q4 Revenue $2.80B - marketscreener.com
Chronic and Acute Pain Clinical Trial Pipeline Analysis: - GlobeNewswire
North American Morning Briefing : Nasdaq Futures Rise; Trade Relations, Earnings in Focus -2 - marketscreener.com
Trevena (NASDAQ:TRVN) Share Price Passes Above Fifty Day Moving Average – Should You Sell? - Defense World
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - The Manila Times
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: - GlobeNewswire
What technical patterns form on Trevena Inc. (6T4) stock chartsJuly 2025 Market Mood & Fast Entry and Exit Trade Plans - bollywoodhelpline.com
Trevena Restructures China Royalty Rights to Exit Debt - The Globe and Mail
Critical Contrast: Ampio Pharmaceuticals (NYSE:AMPE) vs. Trevena (NASDAQ:TRVN) - Defense World
Trevena Signs Assignment and Release Agreement With R-Bridge Investment Four and Jiangsu Nhwa Pharmaceutical - TradingView — Track All Markets
Trevena (NASDAQ:TRVN) Shares Cross Below Fifty Day Moving Average – Here’s What Happened - Defense World
Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors - BioSpace
How Trevena Inc. (6T4) stock valuation compares with sectorQuarterly Portfolio Review & Risk Managed Investment Entry Signals - ulpravda.ru
Analyst Upgrade: How Trevena Inc. (6T4) stock benefits from digital adoptionJuly 2025 Action & Long Hold Capital Preservation Tips - ulpravda.ru
4.65%
1.27%
자본화:
|
볼륨(24시간):